France's Socialist Party Seeks Budget Compromise
France's Socialist Party is open to negotiating the budget, offering a lifeline to Prime Minister Francois Bayrou to prevent government collapse.
Topic
Budget
A collection of 15 issues
Budget Faces Uncertainty with Potential Federal Cuts
Explore how President Donald Trump's potential federal funding cuts could impact the budget, with a third relying on federal funds.
Governor Newsom Proposes Balanced $322 Billion California Budget
California Governor Gavin Newsom unveils a $322 billion budget, marking the end of two years of deficits. Explore the details of this balanced fiscal plan.
Mexico's Budget: Balancing Fiscal Deficit and Pemex Support
Mexican lawmakers approve a budget aimed at reducing the fiscal deficit while ensuring support for state-owned oil company Petroleos Mexicanos (Pemex).
Labour's Borrowing Plan Spurs Gilt Selloff, 10-Year Yield Jumps
Labour's near-record borrowing plan triggers a gilt selloff, boosting the 10-year UK yield by 40 basis points. Read more on the fiscal impact.
Budget Rejection Triggers No-Confidence Vote
Government budget plan rejection leads to a no-confidence vote. Discover the political implications and potential outcomes of this critical decision.
Payroll Tax Hike Triggers Workforce Reduction
Explore the impact of the October budget's payroll tax hike, with 23% of employers reducing headcount. Key insights into employment trends and economic effects.
Brent Crude Dips: Saudi Budget Imbalance Looms
Brent crude prices dip to $76 per barrel, significantly below Saudi Arabia's budget-balancing threshold of $90. Explore the economic implications.
Brent Crude Faces 4% Annual Loss Amid Saudi Budget Concerns
Brent crude oil prices are projected to fall by 4% this year, trading at $74 per barrel. This poses challenges for Saudi Arabia, which requires $93 per barrel to balance its budget.
Roche Maintains Steady R&D Budget
Roche's research and development budget remains unchanged, signaling a stable commitment to innovation. Explore the implications for the pharmaceutical giant's future.